Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs).
Cells. 2019 Sep 25;8(10):1145. doi: 10.3390/cells8101145.
Cells. 2019.
PMID: 31557946
Free PMC article.
Review.
Circulating tumor cells (CTCs) for the noninvasive monitoring and personalization of non-small cell lung cancer (NSCLC) therapies.
Pawlikowska P, Faugeroux V, Oulhen M, Aberlenc A, Tayoun T, Pailler E, Farace F.
Pawlikowska P, et al. Among authors: aberlenc a.
J Thorac Dis. 2019 Jan;11(Suppl 1):S45-S56. doi: 10.21037/jtd.2018.12.80.
J Thorac Dis. 2019.
PMID: 30775027
Free PMC article.
Review.
Item in Clipboard
Tumor Evolution and Therapeutic Choice Seen through a Prism of Circulating Tumor Cell Genomic Instability.
Tayoun T, Oulhen M, Aberlenc A, Farace F, Pawlikowska P.
Tayoun T, et al. Among authors: aberlenc a.
Cells. 2021 Feb 5;10(2):337. doi: 10.3390/cells10020337.
Cells. 2021.
PMID: 33562741
Free PMC article.
Review.
Item in Clipboard
Targeting genome integrity dysfunctions impedes metastatic potency in non-small cell lung cancer circulating tumor cell-derived explants.
Tayoun T, Faugeroux V, Oulhen M, Déas O, Michels J, Brulle-Soumare L, Cairo S, Scoazec JY, Marty V, Aberlenc A, Planchard D, Remon J, Ponce S, Besse B, Kannouche PL, Judde JG, Pawlikowska P, Farace F.
Tayoun T, et al. Among authors: aberlenc a.
JCI Insight. 2022 Jun 8;7(11):e155804. doi: 10.1172/jci.insight.155804.
JCI Insight. 2022.
PMID: 35511434
Free PMC article.
Item in Clipboard
Exploitation of the chick embryo chorioallantoic membrane (CAM) as a platform for anti-metastatic drug testing.
Pawlikowska P, Tayoun T, Oulhen M, Faugeroux V, Rouffiac V, Aberlenc A, Pommier AL, Honore A, Marty V, Bawa O, Lacroix L, Scoazec JY, Chauchereau A, Laplace-Builhe C, Farace F.
Pawlikowska P, et al. Among authors: aberlenc a.
Sci Rep. 2020 Oct 9;10(1):16876. doi: 10.1038/s41598-020-73632-w.
Sci Rep. 2020.
PMID: 33037240
Free PMC article.
Item in Clipboard
Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors.
Oulhen M, Pawlikowska P, Tayoun T, Garonzi M, Buson G, Forcato C, Manaresi N, Aberlenc A, Mezquita L, Lecluse Y, Lavaud P, Naltet C, Planchard D, Besse B, Farace F.
Oulhen M, et al. Among authors: aberlenc a.
NPJ Precis Oncol. 2021 Jul 16;5(1):67. doi: 10.1038/s41698-021-00203-1.
NPJ Precis Oncol. 2021.
PMID: 34272470
Free PMC article.
Item in Clipboard
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer.
Mezquita L, Oulhen M, Aberlenc A, Deloger M, Aldea M, Honore A, Lecluse Y, Howarth K, Friboulet L, Besse B, Planchard D, Farace F.
Mezquita L, et al. Among authors: aberlenc a.
Br J Cancer. 2024 Mar;130(4):682-693. doi: 10.1038/s41416-023-02535-0. Epub 2024 Jan 4.
Br J Cancer. 2024.
PMID: 38177660
Free PMC article.
Item in Clipboard
Cite
Cite